Associations in Rheumatology (10.3.2025)October 3, 2025Dr. Jack Cush reviews the news, journal reports and important associations in rheumatology from…View Resource How Does Your Garden Grow (9.26.2025)September 26, 2025Dr. Jack Cush reviews the news and journal articles from RheumNow.com. Pool therapy, Fibrosis,…View Resource ILD Begins (8.29.2025)August 29, 2025Dr. Jack Cush reviews the news and journal reports from RheumNow.com. This week news…View Resource Emapalumab Approved for MAS in Still’sJuly 22, 2025On June 27th, 2025, the FDA approved emapalumab for macrophage activation syndrome (MAS) in…View Resource NHANES, Numbers, & Risk (7.18.2025)July 18, 2025Dr. Jack Cush reviews the news and journal reports from this past week on…View Resource Manifestations and Treatment in Relapsing PolychondritisJuly 15, 2025A large multicenter cohort study of Relapsing Polychondritis (RP) describes the clinical manifestations and…View Resource Hmmm Really? (7.11.2025)July 11, 2025Dr. Jack Cush reviews the news and journal reports from this past week –…View Resource Overview of the VEXAS SyndromeJuly 9, 2025A current systematic review in Rheumatology addresses the clinical features seen in the VEXAS…View Resource Nurse-Led Treat-to-Target ClinicsJune 17, 2025New studies shared at the 2025 annual EULAR congress in Barcelona highlight the benefits…View Resource EULAR 2025 – Day 4 ReportJune 16, 2025Saturday was the final day of EULAR, and included several lectures, but mostly late…View Resource ←12345…6789101112131415→
How Does Your Garden Grow (9.26.2025)September 26, 2025Dr. Jack Cush reviews the news and journal articles from RheumNow.com. Pool therapy, Fibrosis,…View Resource ILD Begins (8.29.2025)August 29, 2025Dr. Jack Cush reviews the news and journal reports from RheumNow.com. This week news…View Resource Emapalumab Approved for MAS in Still’sJuly 22, 2025On June 27th, 2025, the FDA approved emapalumab for macrophage activation syndrome (MAS) in…View Resource NHANES, Numbers, & Risk (7.18.2025)July 18, 2025Dr. Jack Cush reviews the news and journal reports from this past week on…View Resource Manifestations and Treatment in Relapsing PolychondritisJuly 15, 2025A large multicenter cohort study of Relapsing Polychondritis (RP) describes the clinical manifestations and…View Resource Hmmm Really? (7.11.2025)July 11, 2025Dr. Jack Cush reviews the news and journal reports from this past week –…View Resource Overview of the VEXAS SyndromeJuly 9, 2025A current systematic review in Rheumatology addresses the clinical features seen in the VEXAS…View Resource Nurse-Led Treat-to-Target ClinicsJune 17, 2025New studies shared at the 2025 annual EULAR congress in Barcelona highlight the benefits…View Resource EULAR 2025 – Day 4 ReportJune 16, 2025Saturday was the final day of EULAR, and included several lectures, but mostly late…View Resource ←12345…6789101112131415→
ILD Begins (8.29.2025)August 29, 2025Dr. Jack Cush reviews the news and journal reports from RheumNow.com. This week news…View Resource Emapalumab Approved for MAS in Still’sJuly 22, 2025On June 27th, 2025, the FDA approved emapalumab for macrophage activation syndrome (MAS) in…View Resource NHANES, Numbers, & Risk (7.18.2025)July 18, 2025Dr. Jack Cush reviews the news and journal reports from this past week on…View Resource Manifestations and Treatment in Relapsing PolychondritisJuly 15, 2025A large multicenter cohort study of Relapsing Polychondritis (RP) describes the clinical manifestations and…View Resource Hmmm Really? (7.11.2025)July 11, 2025Dr. Jack Cush reviews the news and journal reports from this past week –…View Resource Overview of the VEXAS SyndromeJuly 9, 2025A current systematic review in Rheumatology addresses the clinical features seen in the VEXAS…View Resource Nurse-Led Treat-to-Target ClinicsJune 17, 2025New studies shared at the 2025 annual EULAR congress in Barcelona highlight the benefits…View Resource EULAR 2025 – Day 4 ReportJune 16, 2025Saturday was the final day of EULAR, and included several lectures, but mostly late…View Resource ←12345…6789101112131415→
Emapalumab Approved for MAS in Still’sJuly 22, 2025On June 27th, 2025, the FDA approved emapalumab for macrophage activation syndrome (MAS) in…View Resource NHANES, Numbers, & Risk (7.18.2025)July 18, 2025Dr. Jack Cush reviews the news and journal reports from this past week on…View Resource Manifestations and Treatment in Relapsing PolychondritisJuly 15, 2025A large multicenter cohort study of Relapsing Polychondritis (RP) describes the clinical manifestations and…View Resource Hmmm Really? (7.11.2025)July 11, 2025Dr. Jack Cush reviews the news and journal reports from this past week –…View Resource Overview of the VEXAS SyndromeJuly 9, 2025A current systematic review in Rheumatology addresses the clinical features seen in the VEXAS…View Resource Nurse-Led Treat-to-Target ClinicsJune 17, 2025New studies shared at the 2025 annual EULAR congress in Barcelona highlight the benefits…View Resource EULAR 2025 – Day 4 ReportJune 16, 2025Saturday was the final day of EULAR, and included several lectures, but mostly late…View Resource ←12345…6789101112131415→
NHANES, Numbers, & Risk (7.18.2025)July 18, 2025Dr. Jack Cush reviews the news and journal reports from this past week on…View Resource Manifestations and Treatment in Relapsing PolychondritisJuly 15, 2025A large multicenter cohort study of Relapsing Polychondritis (RP) describes the clinical manifestations and…View Resource Hmmm Really? (7.11.2025)July 11, 2025Dr. Jack Cush reviews the news and journal reports from this past week –…View Resource Overview of the VEXAS SyndromeJuly 9, 2025A current systematic review in Rheumatology addresses the clinical features seen in the VEXAS…View Resource Nurse-Led Treat-to-Target ClinicsJune 17, 2025New studies shared at the 2025 annual EULAR congress in Barcelona highlight the benefits…View Resource EULAR 2025 – Day 4 ReportJune 16, 2025Saturday was the final day of EULAR, and included several lectures, but mostly late…View Resource ←12345…6789101112131415→
Manifestations and Treatment in Relapsing PolychondritisJuly 15, 2025A large multicenter cohort study of Relapsing Polychondritis (RP) describes the clinical manifestations and…View Resource Hmmm Really? (7.11.2025)July 11, 2025Dr. Jack Cush reviews the news and journal reports from this past week –…View Resource Overview of the VEXAS SyndromeJuly 9, 2025A current systematic review in Rheumatology addresses the clinical features seen in the VEXAS…View Resource Nurse-Led Treat-to-Target ClinicsJune 17, 2025New studies shared at the 2025 annual EULAR congress in Barcelona highlight the benefits…View Resource EULAR 2025 – Day 4 ReportJune 16, 2025Saturday was the final day of EULAR, and included several lectures, but mostly late…View Resource ←12345…6789101112131415→
Hmmm Really? (7.11.2025)July 11, 2025Dr. Jack Cush reviews the news and journal reports from this past week –…View Resource Overview of the VEXAS SyndromeJuly 9, 2025A current systematic review in Rheumatology addresses the clinical features seen in the VEXAS…View Resource Nurse-Led Treat-to-Target ClinicsJune 17, 2025New studies shared at the 2025 annual EULAR congress in Barcelona highlight the benefits…View Resource EULAR 2025 – Day 4 ReportJune 16, 2025Saturday was the final day of EULAR, and included several lectures, but mostly late…View Resource ←12345…6789101112131415→
Overview of the VEXAS SyndromeJuly 9, 2025A current systematic review in Rheumatology addresses the clinical features seen in the VEXAS…View Resource Nurse-Led Treat-to-Target ClinicsJune 17, 2025New studies shared at the 2025 annual EULAR congress in Barcelona highlight the benefits…View Resource EULAR 2025 – Day 4 ReportJune 16, 2025Saturday was the final day of EULAR, and included several lectures, but mostly late…View Resource ←12345…6789101112131415→
Nurse-Led Treat-to-Target ClinicsJune 17, 2025New studies shared at the 2025 annual EULAR congress in Barcelona highlight the benefits…View Resource EULAR 2025 – Day 4 ReportJune 16, 2025Saturday was the final day of EULAR, and included several lectures, but mostly late…View Resource ←12345…6789101112131415→
EULAR 2025 – Day 4 ReportJune 16, 2025Saturday was the final day of EULAR, and included several lectures, but mostly late…View Resource